The specifics, since they change the answer: tirzepatide · list of related substances.
I want to understand what this actually establishes, as opposed to what it is being used to imply.
My concern is that I am being invited to draw a conclusion the data does not support.
Which parts of this are informative and which are decoration?
A useful certificate has five elements: the lot number, the analytical method, the reported result with units, the date of analysis, and the primary data or a reference to it.
Lot number visibility is the first check, and it is the one most certificates fail — the number is not printed on the vial, or it is on the certificate but the vial is unmarked.
The test date matters because a certificate six months older than the vial is not evidence about your material, it is evidence about what the material was like half a year ago.
Industry guidance on this topic is consistent because it comes from first principles rather than convention.
The practical summary: check the lot number, ask for the method, and reserve judgement until you have both.
Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.
Shop standardsBefore anything else, check that the lot number on the certificate matches the vial in your hand — that traces back to your material and not to some other lot from some other date.
Batch versus lot is a semantic distinction that determines whether one certificate applies to ten vials or to one, and checking this distinction is worth a minute.
Mechanically, comparison across certificates from different laboratories is almost never valid, even when the material is the same, because the methods are almost never the same.
The standards that exist in this space — ICH Q3A, Q3B and various pharmacopoeial chapters — are worth reading once even if nothing you test is obliged to meet them.
The caveat is that a certificate is not a guarantee, it is a data point, and treating it as anything else is asking for disappointment.
My working rule is that a document without a lot number, a method section and a test date is marketing.
edited 14 Mar 2026 by a_lindgren — corrected a unit error in the worked example
Mechanically, a certificate without a method section is giving you a claim rather than a measurement, and claims are not evidence.
Multiple testing on the same lot reported in a single document suggests internal quality control; identical figures across different lots suggests the same certificate reused.
Test results from a material supplier are different from independent results in ways that matter for interpretation, even if both are accurate.
Published inter-laboratory comparisons of the same material routinely find spreads of half a per cent to a full per cent, which sets realistic expectations.
If the certificate does not trace to your vial, it is not evidence about your vial.
edited 14 Mar 2026 by pascal_thibault — added a caveat about sampling
On the detail: most certificates are written to look impressive rather than to be informative, and it is worth being sceptical of that gap.
Writing the lot number on your vial in permanent marker is worth doing because it later proves that the certificate traces to your material.
Worth noting that none of this is medical advice, and a compound sold for research use carries no regulatory approval in any jurisdiction.
If you only pay for one test, pay for quantified content. Purity is the number everyone quotes and content is the number that changes what you do.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.